Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velcade and Temsirolimus in Relapsed/Refractory B-cell NHL
NCT01281917Phase 2Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Feb 2011
- Primary completion
- Oct 2013
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib, temsirolimus in B-cell non-Hodgkin lymphoma, sponsored by University of Wisconsin–Madison. Started Feb 2011; status: completed.
02
Drugs
bortezomibtemsirolimus
03
Conditions
B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT01281917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01281917.